CANCER SUPPORT COMMUNITY BENJAMIN CENTER presented its annual Gilda Award Gala in Los Angeles. The organization honored actress Frances Fisher with the Gilda Award; CSC advocate Joyce Green with the Wellness Award; and City of Hope’s Matthew Loscalzo with the Harold H. Benjamin Innovation Award. The event was hosted by John Sencio, a national television […]
CANCERCARE published a report illustrating the physical, emotional, financial, practical and informational needs cancer patients experience during and after clinical treatment. The 2016 Patient Access and Engagement Report analyzed more than 3,000 patients in ethnicity, income, education, geography, age, insurance, cancer type and treatment stage—and evaluated their understanding of their diagnosis and access to care, […]
STAND UP TO CANCER published a series of Certification for Nursing Education training modules, with the Boston College William F. Connell School of Nursing, focused on immunotherapy. The first web-based CNE modules will be available in July. In its first round, the program will seek to train 25 nurses working in immunotherapy. The program was […]
TOM ANDRUS was named chief digital officer and executive vice president of the Prostate Cancer Foundation. Most recently, Andrus was general manager and senior vice president of AXS.com, a division of AEG, building a new ticketing company. Previously, he was senior vice president of product at MySpace, where he led the product, design, mobile, and […]
In their op-ed piece, Gilman and Sharp stated what it would take to fix CPRIT's problems. That was the polite version of the Gilman Plan.The spoken version was more blunt: get rid of the “assholes” on the oversight board, jettison the administrators, then—maybe—CPRIT's credibility would be restored.
A few years ago, at dinner with technology entrepreneur Larry Ellison, David Agus, director of the University of Southern California Center for Applied Molecular Medicine, mentioned his dream of opening an interdisciplinary cancer research center.
During our first conversation in the spring of 2012, Gilman said that he would go public unless he received assurances that CPRIT would retain its integrity after his departure.
Greg Simon, executive director of the cancer moonshot task force, addressed the FDA-sponsored workshop for Accelerating Anticancer Agent Development and Validation in North Bethesda, Md., May 4.
The White House moonshot to accelerate progress in cancer research directs FDA to consolidate its oncology portfolio.
FDA granted Orphan Drug Designation to VAL-083 in the treatment of ovarian cancer. The investigational drug candidate, developed by DelMar Pharmaceuticals Inc., previously received an orphan designation for glioma and medulloblastoma in the United States and glioma in Europe. In more than 40 phase I and II clinical studies sponsored by NCI, VAL-083 demonstrated clinical […]
